Medical treatment of patients with atrial fibrillation aged over 80 years in daily clinical practice: Influence of age and CHADS2 score

被引：6

作者：

Lotze, Ulrich ^{[1
,2
]}

Liebetrau, Johannes ^{[2
]}

Malsch, Ina ^{[2
]}

Fruehwirt, Benita ^{[2
]}

Rothhagen, Brigitte ^{[2
]}

Kharatyan, Natalya ^{[2
]}

Neubauer, Katharina ^{[2
]}

机构：

[1] Saale Unstrut Hosp Naumburg, Dept Internal Med, D-06618 Naumburg, Germany

[2] Hosp Waltershausen Friedrichroda, Dept Internal Med 1, D-99894 Friedrichroda, Germany

来源：

ARCHIVES OF GERONTOLOGY AND GERIATRICS | 2010年 / 50卷 / 01期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

Atrial fibrillation; Medical treatment; Very elderly patients; Age and CHADS(2) score; RANDOMIZED CONTROLLED-TRIAL; MOLECULAR-WEIGHT HEPARIN; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; RHYTHM CONTROL; RISK-FACTORS; ANTICOAGULATION; ASPIRIN; WARFARIN; GUIDELINES;

D O I：

10.1016/j.archger.2009.01.011

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

The purpose of the present study was to evaluate clinical data and medical treatment of very elderly patients with atrial fibrillation (AF) who are under-represented in the majority of AF studies. In this retrospective study, patients over 80 years with AF admitted to the cardiology ward during a 1-year period were investigated with respect to the type of AF, clinical characteristics, and rate or rhythm control strategy. In addition, the influence of age and CHADS(2) score on antithrombotic therapy was examined. A total of 169 consecutive patients (mean +/- S.D. age: 84.7 +/- 4.0 years) were included in this study. Rate control medication was administered in 79% of the patients at discharge. Oral anticoagulation (OAC) was prescribed in only 27.5% of the patients with a CHADS2 score of >= 2 for reasons of poor compliance or unfavorable clinical conditions. Moreover, patients older than 85 years received OAC less frequently than those aged between 80 and 84 years (7% vs. 36%, p < 0.001). Our results indicate a real need for educational programs aimed at instructing all staff involved with this group of patients, so that the necessary pre-conditions for a maximum OAC therapy can be achieved in these very elderly AF patients. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：36 / 41

页数：6

共 28 条

[1]

ACC/AHA/ASE, 2003, GUID UPD CLIN APPL E

[2]

[Anonymous], 1994, ARCH INTERN MED, V154, P1449

[3] Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin®) in atrial fibrillation and TEE-guided cardioversion [J].

Bechtold, H ;

Gunzenhauser, D ;

Sawitzki, H ;

Fung, S ;

Janssen, D .

ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (07) :532-539

[4] Impact of atrial fibrillation on the risk of death [J].

Benjamin, EJ ;

Wolf, PA ;

D'Agostino, RB ;

Silbershatz, H ;

Kannel, WB ;

Levy, D .

CIRCULATION, 1998, 98 (10) :946-952

[5] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].

Connolly, S. ;

Pogue, J. ;

Hart, R. ;

Pfeffer, M. ;

Hohnloser, S. ;

Chrolavicius, S. ;

Yusuf, S. .

LANCET, 2006, 367 (9526) :1903-1912

[6] To anticoagulate or not to anticoagulate? A common dilemma for the provider: Physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation [J].

Dharmarajan, T. S. ;

Varma, Surendran ;

Akkaladevi, Shailaja ;

Lebelt, Anna S. ;

Norkus, Edward P. .

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2006, 7 (01) :23-28

[7] Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].

Dries, DL ;

Exner, DV ;

Gersh, BJ ;

Domanski, MJ ;

Waclawiw, MA ;

Stevenson, LW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703

[8] PREVALENCE OF ATRIAL-FIBRILLATION IN ELDERLY SUBJECTS (THE CARDIOVASCULAR HEALTH STUDY) [J].

FURBERG, CD ;

PSATY, BM ;

MANOLIO, TA ;

GARDIN, JM ;

SMITH, VE ;

RAUTAHARJU, PM .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (03) :236-241

[9] ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -: executive summary -: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, David S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Le Heuzey, Jean-Yves ;

Kay, G. Neal ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, Samuel ;

Priori, Silvia G. ;

Blanc, Jean-Jacques ;

Budaj, Andrzej ;

Camm, John ;

Dean, Veronica ;

Deckers, Jaap W. ;

Despres, Catherine ;

Dickstein, Kenneth ;

Lekakis, John ;

McGregor, Keith ;

Metra, Marco ;

Morais, Joao ;

Osterspey, Ady ;

Tamargo, Juan Luis ;

Zamorano, Jose Luis ;

Smith, Sidney C. ;

Jacobs, Alice K. ;

Adams, Cynthia D. ;

Anderson, Jeffery L. ;

Antman, Elliott M. ;

Halperin, Jonathan L. ;

Hunt, Sharon Ann ;

Nishimura, Rick ;

Ornato, Joseph P. ;

Page, Richard L. ;

Riegel, Barbara .

EUROPEAN HEART JOURNAL, 2006, 27 (16) :1979-2030

[10] Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin [J].

Gage, BF ;

van Walraven, C ;

Pearce, L ;

Hart, RG ;

Koudstaal, PJ ;

Petersen, P .

CIRCULATION, 2004, 110 (16) :2287-2292

← 1 2 3 →